Company intelligence / Profile preview

Viyash Life Sciences

Hyderabad, Telangana, Indiaviyash.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Viyash is a leading Indian integrated pharmaceutical company specializing in the development and manufacture of niche active pharmaceutical ingredients (APIs), advanced intermediates, and generic formulations. It operates ten API/intermediate facilities with a combined capacity of ~2000 KL plus a US-based formulation facility. The company has expanded rapidly through acquisitions—including Symed Labs—and has received investment from Carlyle. In September 2024 it agreed to merge with SeQuent Scientific to create a global leader in animal health pharmaceuticals; the deal is pending final regulatory approval as of mid-2025

Therapeutic areas: Metabolic DisordersOncologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

Carlyle Group (investor/partner)SeQuent Scientific

Beyond the preview

Go deeper on Viyash Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viyash Life Sciences.

Explore the full profile